• The BMJ iPad app brings you the best of print and online, including live links to the latest news, blogs, video, and podcasts. Get the BMJ iPad app.
  • Find out how study types differ in our How to read a paper section.
  • Gastroenterology updates: Access the latest gastroenterology resources from across BMJ Group, including articles, learning modules, podcasts, and blogs.
  • OPEN ACCESS: All research articles are freely available online, with no word limit. Find out more about the BMJ's open access policy. Submit your paper.
  • Keep up to date with diabetes: Access the latest diabetes resources from across BMJ Group, including articles, learning modules, podcasts, and blogs.
  • Keep up to date with cardiology: Access the latest cardiovascular medicine resources from across BMJ Group.
  • Hot topics: We regularly publish more than one article on the same subject simultaneously. Find out more on our article clusters page.
  • Dementia: Access the latest dementia resources from across BMJ Group, including articles, learning modules, podcasts, and blogs.
  • Neurology updates: Access the latest neurology resources from BMJ Group, including articles, learning modules, podcasts, and blogs.
  • Infectious diseases: Access the latest infectious disease resources from across BMJ Group, including articles, learning modules, podcasts, and blogs.
  • Updates from bmj.com: Get RSS feeds of latest articles published at bmj.com/rss

Latest from the BMJ

Research News: Conventional triple therapy as good as etanercept for uncontrolled rheumatoid arthritis

Clinical Review: Acne vulgaris

Practice: Hearing loss in adults

Research News: Duloxetine reduces chemotherapy induced peripheral neuropathy

Practice: Long term follow-up of survivors of childhood cancer: summary of updated SIGN guidance

Clinical Review: Outpatient parenteral antimicrobial therapy

Analysis: NICE’s end of life decision making scheme: impact on population health

Editorial: Advances in the treatment of late stage melanoma

Research News: CABG not PCI for most people with complex coronary artery disease

Analysis: Optional copayments on anti-cancer drugs

See more »